T he Food and Drug Administration on Monday approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people in the latter part of pregnancy.. The vaccine ...

The Pfizer vaccine joins another shot given to babies up to 24 months old. It's technically not a vaccine, but it, too, prevents RSV. It's a monoclonal antibody made by AstraZeneca that was also ...

“A vaccine to help prevent RSV had been an elusive public health goal for more than half a century. Today’s approval is a monumental step forward in delivering on Pfizer’s commitment to help ...

Pfizer’s Abrysvo is now approved for preventing illness caused by respiratory syncytial virus, or RSV, in adults 60 and older. The regulatory decision comes weeks after GSK won approval for its ...

Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and Drug Administration is reportedly expediting its review approval process.

The Food and Drug Administration approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. The company's ...

Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect newborns that it will end enrollment in the study and submit for US Food and Drug ...

Pfizer's RSV vaccine, Abrysvo, was approved for people 60 and older last year. The company said Tuesday that in a Phase 3 clinical trial of people 18 to 59, ...

The Food and Drug Administration on Wednesday approved Pfizer’s vaccine to protect older adults from RSV, weeks after the agency greenlit the very first shot against the common and potentially ...

In Pfizer’s data, the vaccine, called Abrysvo, was 85.7% effective at protecting people against severe RSV—diagnosed as having three or more symptoms of lower respiratory tract disease—among ...

After decades of having no vaccines to fight respiratory syncytial respiratory (RSV), the U.S. now has two—both aimed at protecting older adults. On May 31, the U.S. Food and Drug Administration ...